Carta Acesso aberto Revisado por pares

Evidence for a Link Between Adipose Tissue Interleukin-6 Content and Serum C-Reactive Protein Concentrations in Obese Subjects

1999; Lippincott Williams & Wilkins; Volume: 99; Issue: 16 Linguagem: Inglês

10.1161/circ.99.16.2219/c

ISSN

1524-4539

Autores

Jean‐Philippe Bastard, Claude Jardel, Jacques Delattre, Bernard Hainque, Éric Bruckert, F Oberlin,

Tópico(s)

Cardiovascular Disease and Adiposity

Resumo

HomeCirculationVol. 99, No. 16Evidence for a Link Between Adipose Tissue Interleukin-6 Content and Serum C-Reactive Protein Concentrations in Obese Subjects Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBEvidence for a Link Between Adipose Tissue Interleukin-6 Content and Serum C-Reactive Protein Concentrations in Obese Subjects Jean-Philippe Bastard, Claude Jardel, Jacques Delattre and Bernard Hainque Eric Bruckert Flavien Oberlin Jean-Philippe BastardJean-Philippe Bastard Service de Biochimie B , Claude JardelClaude Jardel Service de Biochimie B , Jacques DelattreJacques Delattre Service de Biochimie B and Bernard HainqueBernard Hainque Service de Biochimie B Eric BruckertEric Bruckert Service d'Endocrinologie-Métabolisme Flavien OberlinFlavien Oberlin Service de Rhumatologie Groupe hospitalier Pitié-Salpêtrière AP-HP, Paris, France Originally published27 Apr 1999https://doi.org/10.1161/circ.99.16.2219/cCirculation. 1999;99:2219c–2222To the Editor:We read with interest the editorial by Tracy1 on inflammation in cardiovascular disease (CVD). Serum concentrations of C-reactive protein (CRP) were demonstrated to be related to increased risk of CVD, which underlines the potential inflammatory nature of human atherosclerosis.23 Interestingly, an unexpected association between CRP and body mass index (BMI) was found in several population studies234 without any explanation.1The production of CRP is regulated by cytokines, principally interleukin-6 (IL-6), and serum CRP levels reflect IL-6 activity in humans. It was demonstrated that IL-6 is released in vivo by subcutaneous adipose tissue and is thereby able to have systemic effects, particularly in obese subjects.5 Thus, we hypothesized that adipose tissue may play a role in the regulation of serum CRP concentrations via IL-6 production.To test this hypothesis, we measured CRP and IL-6 in both blood and adipose tissue from 13 fasting obese subjects (2 men, 11 women) aged 44±4 years (BMI, 39.1±1.3 kg/m2; percent fat mass, 44.3±2.4%). CRP concentrations were determined with a BNII nephelometer analyser (Behring). IL-6 concentrations were determined by ELISA (Quantikine, R&D Systems). Body composition analysis was carried out by dual x-ray absorptiometry (QDR 1000, Hologic).Serum CRP and IL-6 concentrations were 4.49±1.07 mg/L and 2.77±0.31 pg/mL, respectively. In adipose tissue, IL-6 concentrations were 12.81±1.28 pg/g fat, whereas CRP was undetectable. Serum CRP concentrations were significantly correlated with BMI (ρ=0.633, P<0.05), body fat mass (ρ=0.718, P<0.05), and percent fat mass (ρ=0.872, P<0.005) but not with lean body mass (ρ=−0.435, P=0.13). A strong correlation was found between serum CRP concentrations and adipose tissue IL-6 content when expressed as picogram per total fat mass (ρ=0.757, P<0.01) but not as picogram per gram of fat (ρ=0.446, P=0.12).These data are consistent with the role of human adipose tissue in the regulation of blood circulating CRP concentrations via IL-6 production in obesity. In addition, the higher IL-6 production from adipose tissue seems to be more related to the increase of total fat mass than an overexpression of IL-6 in adipose tissue. Because CRP was proposed as a predictive marker of CVD risk, whether slightly elevated concentrations of CRP are the consequence of adipose tissue secretion, an inflammatory process, or both remains to be established. References 1 Tracy RP. Inflammation in cardiovascular disease: cart, horse, or both? Circulation.1998; 97:2000–2002.CrossrefMedlineGoogle Scholar2 Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ.1996; 312:1061–1065.CrossrefMedlineGoogle Scholar3 Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet.1997; 349:462–466.CrossrefMedlineGoogle Scholar4 Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol.1997; 17:2167–2176.CrossrefMedlineGoogle Scholar5 Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab.1997; 82:4196–4200.MedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Park J (2022) Asthma Phenotype with Metabolic Dysfunction, Yonsei Medical Journal, 10.3349/ymj.2022.63.1.1, 63:1, (1), . Roohi E, Jaafari N and Hashemian F (2021) On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?, Journal of Neuroinflammation, 10.1186/s12974-021-02100-7, 18:1, Online publication date: 1-Dec-2021. Alim B, Canturk E and Koksal C (2020) The effect of treated apical periodontitis before heart valve surgery on C‐reactive protein levels, Oral Diseases, 10.1111/odi.13554, 27:3, (632-638), Online publication date: 1-Apr-2021. Kunz H, Hart C, Gries K, Parvizi M, Laurenti M, Dalla Man C, Moore N, Zhang X, Ryan Z, Polley E, Jensen M, Vella A and Lanza I (2021) Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity, American Journal of Physiology-Endocrinology and Metabolism, 10.1152/ajpendo.00070.2021, 321:1, (E105-E121), Online publication date: 1-Jul-2021. Sharif S, Van der Graaf Y, Cramer M, Kapelle L, de Borst G, Visseren F, Westerink J, van Petersen R, Dinther B, Algra A, van der Graaf Y, Grobbee D, Rutten G, Visseren F, de Borst G, Kappelle L, Leiner T and Nathoe H (2021) Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes, Cardiovascular Diabetology, 10.1186/s12933-021-01409-0, 20:1, Online publication date: 1-Dec-2021. Yoo B, Kim S, Shin B, Lee M, Choy Y, Lee K, Heo C and Koh W (2021) Preparation of alginate hydrogel with human-derived adipose tissue to improve fat graft survival and adipogenesis, Journal of Industrial and Engineering Chemistry, 10.1016/j.jiec.2020.12.015, 95, (148-155), Online publication date: 1-Mar-2021. Feyaerts A and Luyten W (2020) Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?, Nutrition, 10.1016/j.nut.2020.110948, 79-80, (110948), Online publication date: 1-Nov-2020. Higgins V, Omidi A, Tahmasebi H, Asgari S, Gordanifar K, Nieuwesteeg M and Adeli K (2019) Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and Adolescents, The Journal of Clinical Endocrinology & Metabolism, 10.1210/clinem/dgz161, 105:4, (e1781-e1797), Online publication date: 1-Apr-2020. Hao Q, Vadgama J and Wang P (2020) CCL2/CCR2 signaling in cancer pathogenesis, Cell Communication and Signaling, 10.1186/s12964-020-00589-8, 18:1, Online publication date: 1-Dec-2020. Paniagua González J and Vidal-Puig A (2019) Obesity in the Pathophysiology of Diabetes The Diabetes Textbook, 10.1007/978-3-030-11815-0_13, (185-213), . Aslam M, John P, Bhatti A, Jahangir S and Kamboh M (2019) Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response, BioMed Research International, 10.1155/2019/3494937, 2019, (1-12), Online publication date: 7-May-2019. Faulkner J and Belin de Chantemèle E (2019) Leptin and Aldosterone Aldosterone, 10.1016/bs.vh.2018.09.003, (265-284), . Tsai Y, Chan Y, Chen Y, Cheng Y and Chang S (2018) Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease, Medicine, 10.1097/MD.0000000000011896, 97:36, (e11896), Online publication date: 1-Sep-2018. Faulkner J, Bruder-Nascimento T and Belin de Chantemèle E (2018) The regulation of aldosterone secretion by leptin, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000384, 27:2, (63-69), Online publication date: 1-Mar-2018. Ozkok A, Atas R, Cinar S, Yilmaz A, Aktas E, Deniz G and Yildiz A (2017) CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients, BMC Nephrology, 10.1186/s12882-017-0663-x, 18:1, Online publication date: 1-Dec-2017. Barosi G, Massa M, Campanelli R, Fois G, Catarsi P, Viarengo G, Villani L, Poletto V, Bosoni T, Magrini U, Gale R and Rosti V (2017) Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease, Leukemia Research, 10.1016/j.leukres.2017.06.004, 60, (18-23), Online publication date: 1-Sep-2017. Hou Y, Liu L, Ding X, Zhao D and Hou W (2016) Structure elucidation, proliferation effect on macrophage and its mechanism of a new heteropolysaccharide from Lactarius deliciosus Gray, Carbohydrate Polymers, 10.1016/j.carbpol.2016.07.064, 152, (648-657), Online publication date: 1-Nov-2016. Lorenzatti A and Retzlaff B (2016) Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?, International Journal of Cardiology, 10.1016/j.ijcard.2016.07.061, 221, (581-586), Online publication date: 1-Oct-2016. Hosford-Donovan A, Nilsson A, Wåhlin-Larsson B and Kadi F (2016) Observational and mechanistic links between C-reactive protein and blood pressure in elderly women, Maturitas, 10.1016/j.maturitas.2016.04.016, 89, (52-57), Online publication date: 1-Jul-2016. Bose S, Maity C and Roy N (2016) INFLAMMATORY MARKERS IN PRE-DIABETICS, Journal of Evolution of Medical and Dental Sciences, 10.14260/jemds/2016/482, 5:35, (2056-2060), Online publication date: 2-May-2016. Sarbijani H, Khoshnia M and Marjani A (2016) The association between Metabolic Syndrome and serum levels of lipid peroxidation and interleukin-6 in Gorgan, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10.1016/j.dsx.2015.09.024, 10:1, (S86-S89), Online publication date: 1-Jan-2016. Chen X and Beddhu S (2015) Nutrition and Chronic Kidney Disease Handbook of Clinical Nutrition and Aging, 10.1007/978-1-4939-1929-1_16, (261-271), . Fontes-Carvalho R, Gonçalves A, Severo M, Lourenço P, Rocha Gonçalves F, Bettencourt P, Leite-Moreira A and Azevedo A (2015) Direct, inflammation-mediated and blood-pressure-mediated effects of total and abdominal adiposity on diastolic function: EPIPorto study, International Journal of Cardiology, 10.1016/j.ijcard.2015.04.250, 191, (64-70), Online publication date: 1-Jul-2015. Awan Z and Genest J (2014) Inflammation modulation and cardiovascular disease prevention, European Journal of Preventive Cardiology, 10.1177/2047487314529350, 22:6, (719-733), Online publication date: 1-Jun-2015. Koutsoukou A, Kyriakopoulou M, Kotanidou A and Economidou F (2015) Obese Patient in Intensive Care Unit Diet and Nutrition in Critical Care, 10.1007/978-1-4614-7836-2_19, (105-118), . Oei L, Rivadeneira F, Zillikens M and Oei E (2015) Diabetes, Diabetic Complications, and Fracture Risk, Current Osteoporosis Reports, 10.1007/s11914-015-0260-5, 13:2, (106-115), Online publication date: 1-Apr-2015. Vitulli P, Frati G and Benedetto U (2015) Bilateral internal mammary artery grafting in obese: Outcomes, concerns and controversies, International Journal of Surgery, 10.1016/j.ijsu.2015.01.010, 16, (158-162), Online publication date: 1-Apr-2015. Arjunan S, Deighton K, Bishop N, King J, Reischak-Oliveira A, Rogan A, Sedgwick M, Thackray A, Webb D and Stensel D (2015) The effect of prior walking on coronary heart disease risk markers in South Asian and European men, European Journal of Applied Physiology, 10.1007/s00421-015-3269-7, 115:12, (2641-2651), Online publication date: 1-Dec-2015. Vors C, Gayet-Boyer C and Michalski M (2015) Produits laitiers et inflammation métabolique : quels liens en phase postprandiale et à long terme ?, Cahiers de Nutrition et de Diététique, 10.1016/j.cnd.2014.12.001, 50:1, (25-38), Online publication date: 1-Mar-2015. Szabó C, Kelemen O and Kéri S (2014) Low-grade inflammation disrupts structural plasticity in the human brain, Neuroscience, 10.1016/j.neuroscience.2014.06.002, 275, (81-88), Online publication date: 1-Sep-2014. Card N, Garver W and Orlando R (2014) Additive effects of β-adrenergic and cytokine signaling on lipolytic activation, F1000Research, 10.12688/f1000research.4151.1, 3, (134) Koutsoukou A, Kyriakopoulou M, Kotanidou A and Ekonomidou F (2014) Obese Patient in Intensive Care Unit Diet and Nutrition in Critical Care, 10.1007/978-1-4614-8503-2_19-1, (1-16), . Litvinova L, Atochin D, Vasilenko M, Fattakhov N, Zatolokin P, Vaysbeyn I and Kirienkova E (2014) Role of adiponectin and proinflammatory gene expression in adipose tissue chronic inflammation in women with metabolic syndrome, Diabetology & Metabolic Syndrome, 10.1186/1758-5996-6-137, 6:1, Online publication date: 1-Dec-2014. Khoury M, Manlhiot C and McCrindle B (2013) Role of the Waist/Height Ratio in the Cardiometabolic Risk Assessment of Children Classified by Body Mass Index, Journal of the American College of Cardiology, 10.1016/j.jacc.2013.01.026, 62:8, (742-751), Online publication date: 1-Aug-2013. Faber D, van der Graaf Y, Westerink J, Kanhai D, Monajemi H and Visseren F (2013) Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposity, European Journal of Clinical Investigation, 10.1111/eci.12054, 43:4, (369-378), Online publication date: 1-Apr-2013. Herouvi D, Karanasios E, Karayianni C and Karavanaki K (2013) Cardiovascular disease in childhood: the role of obesity, European Journal of Pediatrics, 10.1007/s00431-013-1932-8, 172:6, (721-732), Online publication date: 1-Jun-2013. Amaral W, Lubach G, Bennett A and Coe C (2013) Inflammatory vulnerability associated with the rh5-HTTLPR genotype in juvenile rhesus monkeys, Genes, Brain and Behavior, 10.1111/gbb.12023, 12:3, (353-360), Online publication date: 1-Apr-2013. Kawamoto R, Kusunoki T, Abe M, Kohara K and Miki T (2013) An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons, Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 10.1177/0004563212473445, 50:5, (457-464), Online publication date: 1-Sep-2013. Smith M and Minson C (2012) Obesity and adipokines: effects on sympathetic overactivity, The Journal of Physiology, 10.1113/jphysiol.2011.221036, 590:8, (1787-1801), Online publication date: 15-Apr-2012. Wykretowicz A, Rutkowska A, Krauze T, Przymuszala D, Guzik P, Marciniak R and Wysocki H (2012) Pulse pressure amplification in relation to body fatness, British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.2011.04129.x, 73:4, (546-552), Online publication date: 1-Apr-2012. Rius-Ottenheim N, de Craen A, Geleijnse J, Slagboom P, Kromhout D, van der Mast R, Zitman F, Westendorp R and Giltay E (2011) C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects, Inflammation Research, 10.1007/s00011-011-0387-5, 61:1, (43-51), Online publication date: 1-Jan-2012. Borné Y, Engström G, Essén B and Hedblad B (2012) Immigrant status and increased risk of heart failure: the role of hypertension and life-style risk factors, BMC Cardiovascular Disorders, 10.1186/1471-2261-12-20, 12:1, Online publication date: 1-Dec-2012. Euteneuer F, Mills P, Rief W, Ziegler M and Dimsdale J (2012) Association of In Vivo β-Adrenergic Receptor Sensitivity With Inflammatory Markers in Healthy Subjects, Psychosomatic Medicine, 10.1097/PSY.0b013e318245d762, 74:3, (271-277), Online publication date: 1-Apr-2012. Spoto B, Leonardis D, Parlongo R, Pizzini P, Pisano A, Cutrupi S, Testa A, Tripepi G, Zoccali C and Mallamaci F (2012) Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2011.01.005, 22:11, (981-988), Online publication date: 1-Nov-2012. López-Jiménez F and Cortés-Bergoderi M (2011) Obesidad y corazón, Revista Española de Cardiología, 10.1016/j.recesp.2010.10.010, 64:2, (140-149), Online publication date: 1-Feb-2011. López-Jiménez F and Cortés-Bergoderi M (2011) Obesity and the Heart, Revista Española de Cardiología (English Edition), 10.1016/j.rec.2010.10.011, 64:2, (140-149), Online publication date: 1-Feb-2011. Capuron L, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot J, Basdevant A, Layé S and Clément K (2010) Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation, Psychological Medicine, 10.1017/S0033291710001984, 41:7, (1517-1528), Online publication date: 1-Jul-2011. Azuma T, Tomofuji T, Endo Y, Tamaki N, Ekuni D, Irie K, Kasuyama K, Kato T and Morita M (2011) Effects of exercise training on gingival oxidative stress in obese rats, Archives of Oral Biology, 10.1016/j.archoralbio.2011.01.008, 56:8, (768-774), Online publication date: 1-Aug-2011. Murray C, Canoy D, Buchan I, Woodcock A, Simpson A and Custovic A (2010) Body mass index in young children and allergic disease: gender differences in a longitudinal study, Clinical & Experimental Allergy, 10.1111/j.1365-2222.2010.03598.x, 41:1, (78-85), Online publication date: 1-Jan-2011. Capuron L and Miller A (2011) Immune system to brain signaling: Neuropsychopharmacological implications, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2011.01.014, 130:2, (226-238), Online publication date: 1-May-2011. Skloot G, Schechter C, Desai A and Togias A (2011) Impaired response to deep inspiration in obesity, Journal of Applied Physiology, 10.1152/japplphysiol.01155.2010, 111:3, (726-734), Online publication date: 1-Sep-2011. Kaya C, Pabuccu R, Berker B and Satıroglu H (2010) Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors, Fertility and Sterility, 10.1016/j.fertnstert.2008.10.070, 93:4, (1200-1207), Online publication date: 1-Mar-2010. Mauras N, DelGiorno C, Kollman C, Bird K, Morgan M, Sweeten S, Balagopal P and Damaso L (2010) Obesity without Established Comorbidities of the Metabolic Syndrome Is Associated with a Proinflammatory and Prothrombotic State, Even before the Onset of Puberty in Children, The Journal of Clinical Endocrinology & Metabolism, 10.1210/jc.2009-1887, 95:3, (1060-1068), Online publication date: 1-Mar-2010. Reed J, De Souza M and Williams N (2010) Effects of exercise combined with caloric restriction on inflammatory cytokines, Applied Physiology, Nutrition, and Metabolism, 10.1139/H10-046, 35:5, (573-582), Online publication date: 1-Oct-2010. Endo Y, Tomofuji T, Ekuni D, Irie K, Azuma T, Tamaki N, Yamamoto T and Morita M (2010) Experimental Periodontitis Induces Gene Expression of Proinflammatory Cytokines in Liver and White Adipose Tissues in Obesity, Journal of Periodontology, 10.1902/jop.2009.090574, 81:4, (520-526), Online publication date: 1-Apr-2010. Zuliani G, Galvani M, Maggio M, Volpato S, Bandinelli S, Corsi A, Lauretani F, Cherubini A, Guralnik J, Fellin R and Ferrucci L (2010) Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance, Atherosclerosis, 10.1016/j.atherosclerosis.2010.08.074, 213:1, (319-324), Online publication date: 1-Nov-2010. Beddhu S (2009) Nutrition and Chronic Kidney Disease Handbook of Clinical Nutrition and Aging, 10.1007/978-1-60327-385-5_21, (403-415), . Aminzadeh M, Pahl M, Barton C, Doctor N and Vaziri N (2009) Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor- in visceral adipocytes, Nephrology Dialysis Transplantation, 10.1093/ndt/gfp405, 24:12, (3626-3631), Online publication date: 1-Dec-2009. Aiello A and Kaplan G (2009) Socioeconomic Position and Inflammatory and Immune Biomarkers of Cardiovascular Disease: Applications to the Panel Study of Income Dynamics, Biodemography and Social Biology, 10.1080/19485560903382304, 55:2, (178-205), Online publication date: 3-Dec-2009. Huber J, Kiefer F, Zeyda M, Ludvik B, Silberhumer G, Prager G, Zlabinger G and Stulnig T (2008) CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity, The Journal of Clinical Endocrinology & Metabolism, 10.1210/jc.2007-2630, 93:8, (3215-3221), Online publication date: 1-Aug-2008. Bouwman J, Visseren F, Bouter K and Diepersloot R (2008) Infection-induced inflammatory response of adipocytes in vitro, International Journal of Obesity, 10.1038/ijo.2008.36, 32:6, (892-901), Online publication date: 1-Jun-2008. Guven M, Bulut Y, Aladag I, Yelken K and Erdoğan H (2007) Serum leptin levels in patients with nasal polyposis, The Journal of Laryngology & Otology, 10.1017/S002221510700967X, 122:6, (590-592), Online publication date: 1-Jun-2008. Li P, Kwan B, Szeto C and Ko G (2008) Metabolic syndrome in peritoneal dialysis patients, Clinical Kidney Journal, 10.1093/ndtplus/sfn073, 1:4, (206-214), Online publication date: 1-Aug-2008. Bays H, González-Campoy J, Bray G, Kitabchi A, Bergman D, Schorr A, Rodbard H and Henry R (2014) Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Review of Cardiovascular Therapy, 10.1586/14779072.6.3.343, 6:3, (343-368), Online publication date: 1-Mar-2008. Rausch M, Weisberg S, Vardhana P and Tortoriello D (2007) Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration, International Journal of Obesity, 10.1038/sj.ijo.0803744, 32:3, (451-463), Online publication date: 1-Mar-2008. Ben Sahra I, Le Marchand Brustel Y, Tanti J and Bost F (2008) Obésité et cancers du côlon et de la prostate: implication des adipokinesObesity and colon and prostate cancer: role of adipokines, Obésité, 10.1007/s11690-008-0118-4, 3:2, (72-77), Online publication date: 1-Jun-2008. Al-Hamdan A, Al-Huthail R, Alsaif M, Al-Othman A, Al-Muammer M, Al-Orf S, Saeed A and Mohamed B (2008) The Effect of Weight Reduction Diet on C-Reactive Protein Level in Obese-Adult Subjects, Journal of Medical Sciences, 10.3923/jms.2009.17.23, 9:1, (17-23), Online publication date: 15-Dec-2008. Vilarrasa N, Vendrell J, Sánchez-Santos R, Broch M, Megia A, Masdevall C, Gomez N, Soler J, Pujol J, Bettónica C, Aranda H and Gómez J (2007) Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-α receptors, C-reactive protein and adiponectin in morbidly obese patients, Clinical Endocrinology, 10.1111/j.1365-2265.2007.02945.x, 67:5, (679-686), Online publication date: 1-Nov-2007. González F, Rote N, Minium J, O'Leary V and Kirwan J (2007) Obese Reproductive-Age Women Exhibit a Proatherogenic Inflammatory Response During Hyperglycemia**, Obesity, 10.1038/oby.2007.289, 15:10, (2436-2444), Online publication date: 1-Oct-2007. Kwan B and Beddhu S (2007) CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: A Story Half Untold: Adiposity, Adipokines and Outcomes in Dialysis Population, Seminars in Dialysis, 10.1111/j.1525-139X.2007.00358.x, 20:6, (493-497) Berberoglu Z, Gursoy A, Bayraktar N, Yazici A, Bascil Tutuncu N and Guvener Demirag N (2007) Rosiglitazone Decreases Serum Bone-Specific Alkaline Phosphatase Activity in Postmenopausal Diabetic Women, The Journal of Clinical Endocrinology & Metabolism, 10.1210/jc.2007-0431, 92:9, (3523-3530), Online publication date: 1-Sep-2007. Poirier P and Eckel R (2007) Cardiovascular Complications of Obesity and the Metabolic Syndrome Cardiovascular Medicine, 10.1007/978-1-84628-715-2_132, (2693-2720), . Choi K, Ryu O, Lee K, Kim H, Seo J, Kim S, Kim N, Choi D and Baik S (2007) Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome, Diabetes Research and Clinical Practice, 10.1016/j.diabres.2006.06.019, 75:2, (235-240), Online publication date: 1-Feb-2007. Yang K, Xie G, Zhang Z, Wang C, Li W, Zhou W and Tang Y (2016) Levels of Serum Interleukin (IL)-6, IL-1β, Tumour Necrosis Factor-α and Leptin and Their Correlation in Depression, Australian & New Zealand Journal of Psychiatry, 10.1080/00048670601057759, 41:3, (266-273), Online publication date: 1-Mar-2007. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A and Dandona P (2006) Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects, Diabetologia, 10.1007/s00125-006-0508-9, 50:2, (278-285), Online publication date: 5-Jan-2007. Ramkumar N, Murtaugh M, Cheung A and Beddhu S (2007) Lack of Synergistic Effects of Metabolic Syndrome and Plasma Fibrinogen on Coronary Events and Mortality in Moderate CKD, American Journal of Kidney Diseases, 10.1053/j.ajkd.2006.12.015, 49:3, (356-364), Online publication date: 1-Mar-2007. VADDI K (2007) TNF SIGNALING PATHWAY INHIBITORS FOR INFLAMMATION-CCR2 ANTAGONISTS Target Validation in Drug Discovery, 10.1016/B978-012369393-8/50013-4, (223-240), . Beddhu S and Kwan B Adiposity and Kidney Disease Adipose Tissue and Adipokines in Health and Disease, 10.1007/978-1-59745-370-7_26, (351-358) Taylor V and MacQueen G (2007) Cognitive dysfunction associated with metabolic syndrome, Obesity Reviews, 10.1111/j.1467-789X.2007.00401.x, 8:5, (409-418), Online publication date: 1-Sep-2007. Ünal M, Eskandari G, Muşlu N, Pata Y and Akbaş Y (2016) Serum Leptin Levels in Patients with Allergic Rhinitis, Otolaryngology–Head and Neck Surgery, 10.1016/j.otohns.2005.11.021, 134:2, (331-333), Online publication date: 1-Feb-2006. TELI T, XANTHAKI D and KARALIS K (2006) Regulation of Appetite and Insulin Signaling in Inflammatory States, Annals of the New York Academy of Sciences, 10.1196/annals.1367.022, 1083:1, (319-328), Online publication date: 1-Nov-2006. Wörns M, Victor A, Galle P and Höhler T (2006) Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels – a study in twins, Genes & Immunity, 10.1038/sj.gene.6364330, 7:7, (600-605), Online publication date: 1-Oct-2006. Kushner I, Rzewnicki D and Samols D (2006) What Does Minor Elevation of C-Reactive Protein Signify?, The American Journal of Medicine, 10.1016/j.amjmed.2005.06.057, 119:2, (166.e17-166.e28), Online publication date: 1-Feb-2006. Kim O, Koh S, Jang Y, Chae J, Kim J, Kim H, Cho H and Lee J (2006) Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: Cross-sectional analysis, Clinica Chimica Acta, 10.1016/j.cca.2006.01.021, 370:1-2, (63-71), Online publication date: 1-Aug-2006. González F, Minium J, Rote N and Kirwan J (2006) Altered tumor necrosis factor α release from mononuclear cells of obese reproductive-age women during hyperglycemia, Metabolism, 10.1016/j.metabol.2005.08.022, 55:2, (271-276), Online publication date: 1-Feb-2006. IWASAKI T, NAKAJIMA A, YONEDA M and TERAUCHI Y (2006) Relationship between the Serum Concentrations of C-reactive Protein and Parameters of Adiposity and Insulin Resistance in Patients with Type 2 Diabetes Mellitus, Endocrine Journal, 10.1507/endocrj.K05-133, 53:3, (345-356), . Shin M, Hyun Y, Kim O, Kim J, Jang Y and Lee J (2006) Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women, International Journal of Obesity, 10.1038/sj.ijo.0803304, 30:10, (1529-1534), Online publication date: 1-Oct-2006. Weisberg S, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel R and Jr. A (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding, Journal of Clinical Investigation, 10.1172/JCI24335, 116:1, (115-124), Online publication date: 4-Jan-2006. Azar R, Sarkis A, Salameh E, Gannagé-Yared M, Amm-Azar M, Badaoui G, Germanos M and Kassab R (2006) Percutaneous coronary intervention increases leptin and decreases adiponectin levels, Clinical Endocrinology, 10.1111/j.1365-2265.2006.02654.x, 65:6, (712-716), Online publication date: 1-Dec-2006. Fain J (2006) Release of Interleukins and Other Inflammatory Cytokines by Human Adipose Tissue Is Enhanced in Obesity and Primarily due to the Nonfat Cells Interleukins, 10.1016/S0083-6729(06)74018-3, (443-477), . Hoekstra T, Geleijnse J, Schouten E, Kok F and Kluft C (2005) Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2005.01.004, 15:4, (270-278), Online publication date: 1-Aug-2005. Beddhu S, Kimmel P, Ramkumar N and Cheung A (2005) Associations of Metabolic Syndrome With Inflammation in CKD: Results From the Third National Health and Nutrition Examination Survey (NHANES III), American Journal of Kidney Diseases, 10.1053/j.ajkd.2005.06.014, 46:4, (577-586), Online publication date: 1-Oct-2005. Desideri G, De Simone M, Iughetti L, Rosato T, Iezzi M, Marinucci M, Cofini V, Croce G, Passacquale G, Necozione S and Ferri C (2005) Early Activation of Vascular Endothelial Cells and Platelets in Obese Children, The Journal of Clinical Endocrinology & Metabolism, 10.1210/jc.2004-1741, 90:6, (3145-3152), Online publication date: 1-Jun-2005. McCarty M (2005) Secondary hyperparathyroidism promotes the ac

Referência(s)
Altmetric
PlumX